Scripps Gets Additional Patent for Gene Technology Licensed to Digital Gene

Mar 24, 2000

Premium

L

A JOLLA, Calif.--An additional patent has been issued to support the underlying technology used by Digital Gene Technologies’ Toga total gene expression analysis method. Issued to the Scripps Research Institute and licensed exclusively to Digital Gene, the patent is the third in a series that covers components of Toga and extends the intellectual property covered by the company’s earlier patents, also licensed exclusively from Scripps.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Nov

05

Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Main menu